These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25888721)
1. Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation. Zhou X; Chen R; Yu Z; Li R; Li J; Zhao X; Song S; Liu J; Huang G Mol Cancer; 2015 Mar; 14():63. PubMed ID: 25888721 [TBL] [Abstract][Full Text] [Related]
2. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281 [TBL] [Abstract][Full Text] [Related]
3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
4. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A; Kant S; Singh SM Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182 [TBL] [Abstract][Full Text] [Related]
5. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors. Zhang W; Hu X; Zhou W; Tam KY J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity. Trapella C; Voltan R; Melloni E; Tisato V; Celeghini C; Bianco S; Fantinati A; Salvadori S; Guerrini R; Secchiero P; Zauli G J Med Chem; 2016 Jan; 59(1):147-56. PubMed ID: 26653539 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452 [TBL] [Abstract][Full Text] [Related]
8. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment. Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. Choi YW; Lim IK Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191 [TBL] [Abstract][Full Text] [Related]
10. Combination of Taxol® and dichloroacetate results in synergistically inhibitory effects on Taxol-resistant oral cancer cells under hypoxia. Xie Q; Zhang HF; Guo YZ; Wang PY; Liu ZS; Gao HD; Xie WL Mol Med Rep; 2015 Apr; 11(4):2935-40. PubMed ID: 25502361 [TBL] [Abstract][Full Text] [Related]
11. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro. Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833 [TBL] [Abstract][Full Text] [Related]
12. Dual-targeting of aberrant glucose metabolism in glioblastoma. Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202 [TBL] [Abstract][Full Text] [Related]
13. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. Pathak RK; Marrache S; Harn DA; Dhar S ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941 [TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma. Li C; Meng G; Su L; Chen A; Xia M; Xu C; Yu D; Jiang A; Wei J Oncotarget; 2015 Jan; 6(3):1544-55. PubMed ID: 25575816 [TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity. Ohashi T; Akazawa T; Aoki M; Kuze B; Mizuta K; Ito Y; Inoue N Int J Cancer; 2013 Sep; 133(5):1107-18. PubMed ID: 23420584 [TBL] [Abstract][Full Text] [Related]
16. Targeting of two aspects of metabolism in breast cancer treatment. Gang BP; Dilda PJ; Hogg PJ; Blackburn AC Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950 [TBL] [Abstract][Full Text] [Related]
17. Metabolic targeting as an anticancer strategy: dawn of a new era? Pan JG; Mak TW Sci STKE; 2007 Apr; 2007(381):pe14. PubMed ID: 17426345 [TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. Vella S; Conti M; Tasso R; Cancedda R; Pagano A Int J Cancer; 2012 Apr; 130(7):1484-93. PubMed ID: 21557214 [TBL] [Abstract][Full Text] [Related]
19. Dichloroacetate and cancer: new home for an orphan drug? Kankotia S; Stacpoole PW Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of breast cancer cells to paclitaxel by dichloroacetate through inhibiting autophagy. Wang M; Liao C; Hu Y; Qinwen Pan ; Jiang J Biochem Biophys Res Commun; 2017 Jul; 489(2):103-108. PubMed ID: 28528979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]